NCT03750669 2025-05-13
Sequential Use of AG and mFOLFIRINOX as Neoadjuvant Chemotherapy for Resectable Pancreatic Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University
Phase 3 Completed
Second Affiliated Hospital, School of Medicine, Zhejiang University
Eastern Cooperative Oncology Group
AIO-Studien-gGmbH
Dartmouth-Hitchcock Medical Center
AIO-Studien-gGmbH
Roswell Park Cancer Institute
National Cancer Institute (NCI)
VA Office of Research and Development